It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Papua New Guinea (PNG) has the highest malaria transmission outside of Africa. Long-lasting insecticidal nets (LLINs) are believed to have helped to reduce average malaria prevalence in PNG from 16% in 2008 to 1% in 2014. Since 2015 malaria in PNG has resurged significantly. Here, we present observations documenting decreased bioefficacy of unused LLINs with manufacturing dates between 2013 and 2019 collected from villages and LLIN distributors in PNG. Specifically, we show that of n = 167 tested LLINs manufactured after 2013, only 17% are fulfilling the required World Health Organisation bioefficacy standards of ≥ 80% 24 h mortality or ≥ 95% 60 min knockdown in bioassays with pyrethroid susceptible Anopheles farauti mosquitoes. In contrast, all (100%, n = 25) LLINs with manufacturing dates prior to 2013 are meeting these bioefficacy standards. These results suggest that decreased bioefficacy of LLINs is contributing to the malaria resurgence in PNG and increased scrutiny of LLIN quality is warranted.
Malaria prevalence in Papua New Guinea has risen in recent years after almost a decade of decline. In this study, the authors demonstrate that long-lasting insecticidal nets used in the country that were manufactured since 2013 have significantly reduced bioefficacy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Robinson, Leanne J 3 ; Kaman, Peter 1 ; Muker, Sakur 1 ; Makita, Leo 4 ; Reimer, Lisa 5
; Schofield, Louis 6 ; Pomat, William 1 ; Mueller, Ivo 7
; Laman Moses 1
; Freeman, Tim 8 ; Stephan, Karl 2
1 PNG Institute of Medical Research, Vector-borne Diseases Unit, Madang, Papua New Guinea (GRID:grid.417153.5) (ISNI:0000 0001 2288 2831)
2 PNG Institute of Medical Research, Vector-borne Diseases Unit, Madang, Papua New Guinea (GRID:grid.417153.5) (ISNI:0000 0001 2288 2831); James Cook University, Australian Institute of Tropical Health and Medicine, Smithfield, Australia (GRID:grid.1011.1) (ISNI:0000 0004 0474 1797)
3 PNG Institute of Medical Research, Vector-borne Diseases Unit, Madang, Papua New Guinea (GRID:grid.417153.5) (ISNI:0000 0001 2288 2831); Burnet Institute, Melbourne, Australia (GRID:grid.1056.2) (ISNI:0000 0001 2224 8486)
4 National Department of Health, Port Moresby, Papua New Guinea (GRID:grid.452626.1)
5 Liverpool School of Tropical Medicine, Liverpool, UK (GRID:grid.48004.38) (ISNI:0000 0004 1936 9764)
6 James Cook University, Australian Institute of Tropical Health and Medicine, Smithfield, Australia (GRID:grid.1011.1) (ISNI:0000 0004 0474 1797)
7 Walter and Eliza Hall Institute of Medical Research, 1G, Parkville, Australia (GRID:grid.1042.7)
8 Rotarians Against Malaria, Port Moresby, Papua New Guinea (GRID:grid.417153.5)




